PKM and neoplasm: To optimize therapeutic precision, metabolic flux analysis employing hyperpolarized 13C-pyruvate tracers provides real-time quantification of PKM2 modulator effects on glycolytic activity, enabling dynamic dose adjustment based on tumor-specific metabolic vulnerabilities.